✦ LIBER ✦

C0131 Comparison of the efficacy and safety of dabigatran, rivaroxaban and apixaban in patients with non-valvular atrial fibrillation using network meta-analysis

✍ Scribed by Marx, Svetlana; Harenberg, Job; Wehling, Martin; Weiss, Christel; Diener, Hans-Christoph; Marder, Victor J.; Lip, Gregory Y.H.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Meta-Analysis of Efficacy and Safety of

✍ Corey S. Miller; Sonia M. Grandi; Avi Shimony; Kristian B. Filion; Mark J. Eisen 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 926 KB

Comparison of cost-effectiveness of anti

✍ Krejczy, Martin; Harenberg, Job; Marx, Svetlana; Obermann, Konrad; Frölich, Lutz 📂 Article 📅 2013 🏛 Springer US 🌐 English ⚖ 461 KB

Meta-Analysis of Efficacy and Safety of

✍ Aryal, Madan Raj; Ukaigwe, Anene; Pandit, Anil; Karmacharya, Paras; Pradhan, Raj 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 283 KB

Comparative Effectiveness of Dabigatran,

✍ Pink, J. (author);Pirmohamed, M. (author);Hughes, D. A. (author) 📂 Article 📅 2013 🏛 Nature Publishing Group 🌐 English ⚖ 781 KB

Comparative Effectiveness of Dabigatran,

✍ Pink, J. (author);Pirmohamed, M. (author);Hughes, D. A. (author) 📂 Article 📅 2013 🏛 Nature Publishing Group 🌐 English ⚖ 781 KB

Cost-Effectiveness Analysis of Apixaban

✍ Canal Fontcuberta, C.; Escolar Albaladejo, G.; Betegón Nicolás, L.; de Salas-Can 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 61 KB